374 filings
Page 8 of 19
8-K
THER
Theralink Technologies, Inc.
29 Dec 17
Cost Associated with Exit or Disposal Activities
12:00am
10-Q
2017 Q3
THER
Theralink Technologies, Inc.
Quarterly report
20 Nov 17
12:00am
NT 10-Q
THER
Theralink Technologies, Inc.
14 Nov 17
Notice of late quarterly filing
12:00am
10-Q
2017 Q2
THER
Theralink Technologies, Inc.
Quarterly report
14 Sep 17
12:00am
NT 10-Q
THER
Theralink Technologies, Inc.
14 Aug 17
Notice of late quarterly filing
12:00am
8-K
THER
Theralink Technologies, Inc.
26 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
THER
Theralink Technologies, Inc.
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
10-Q
2017 Q1
THER
Theralink Technologies, Inc.
Quarterly report
22 May 17
12:00am
424B3
THER
Theralink Technologies, Inc.
16 May 17
Prospectus supplement
12:00am
EFFECT
THER
Theralink Technologies, Inc.
15 May 17
Notice of effectiveness
12:00am
NT 10-Q
THER
Theralink Technologies, Inc.
15 May 17
Notice of late quarterly filing
12:00am
CORRESP
THER
Theralink Technologies, Inc.
12 May 17
Correspondence with SEC
12:00am
POS AM
THER
Theralink Technologies, Inc.
12 May 17
Prospectus update (post-effective amendment)
12:00am
UPLOAD
THER
Theralink Technologies, Inc.
11 May 17
Letter from SEC
12:00am
POS AM
THER
Theralink Technologies, Inc.
1 May 17
Prospectus update (post-effective amendment)
12:00am
8-K
THER
Theralink Technologies, Inc.
21 Apr 17
Departure of Directors or Certain Officers
12:00am
4/A
THER
Theralink Technologies, Inc.
20 Apr 17
OncBioMune Pharmaceuticals / JONATHAN FREDERICK HEAD ownership change
12:00am
4
THER
Theralink Technologies, Inc.
20 Apr 17
OncBioMune Pharmaceuticals / CHARLES L RICE JR ownership change
12:00am
4
Kucharchuk Andrew Albert
20 Apr 17
OncBioMune Pharmaceuticals / ANDREW ALBERT KUCHARCHUK ownership change
12:00am
4
Daniel S. Hoverman
20 Apr 17
OncBioMune Pharmaceuticals / Daniel S. Hoverman ownership change
12:00am